Havana, July 20 (RHC)-- The members of the 32nd Pastors for Peace Friendshipment Caravan on Wednesday expressed their admiration for the achievements made by Cuba in developing biotechnology.

They agreed that such results were achieved despite the limitations imposed by the economic, commercial, and financial blockade imposed by the United States on Cuba for more than half a century.

At the Center for Genetic Engineering and Biotechnology (CIGB) in western Havana, they learned first-hand about the creation and development of vaccines to fight Covid-19, a disease caused by the SARS-CoV-2 coronavirus.

They acknowledged the efforts that Cuba has made to achieve high levels of immunization, placing it at the head of the world regarding the population vaccinated against the pandemic.

Another achievement made by Cuba is the treatment with CIGB’s Heberprot-P, which has reduced the risk of amputation in patients with diabetic foot ulcers by a high percentage in the Cuban population, Dr. Manuel Raices explained.

Heberon® Alfa R, another product, contains recombinant human interferon alfa 2b and is an important biological response modifier, antiviral, antiproliferative, and immunomodulatory.

It offers an excellent therapeutic response to viral and immunological diseases and neoplasms.

Another triumph of Cuba’s science is the innovative Jusvinza therapy for patients in serious or critical condition due to Covid-19 in whom a state of hyper inflammation is suspected or identified. It is also indicated to treat patients with rheumatoid arthritis.